Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelyrin, Actimed, Affibody, Antios, Atai, Braxia, Cabaletta, Centessa, Cidara, Galera, Gensight, IGC, Immunic, Inmagene, Inovio, Kempharm, Kiora, Leo, Medivir, Nrx, Onkure, Oramed, Oravax, Ose, Pfizer, Servier, Sterna.